A shift in thinking to reduce mother-to-infant transmission of hepatitis B

New England Journal of Medicine

Volumn 378, Issue 10, 2018, Pages 952-953

  Dusheiko, Geoffrey ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; DIPHTHERIA PERTUSSIS POLIOMYELITIS TETANUS HAEMOPHILUS INFLUENZAE TYPE B HEPATITIS B VACCINE; HEPATITIS B ANTIBODY; HEPATITIS B VACCINE; HEPATITIS B(E) ANTIGEN; LAMIVUDINE; PLACEBO; TELBIVUDINE; TENOFOVIR DISOPROXIL; VIRUS DNA;

DISEASE TRANSMISSION; EDITORIAL; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNIZATION; IMMUNOGENICITY; INFECTION PREVENTION; MIXED INFECTION; MORBIDITY; MORTALITY; MOTHER TO INFANT TRANSMISSION; NONHUMAN; PERINATAL INFECTION; PREGNANCY; PRIORITY JOURNAL; SIDE EFFECT; FEMALE; INFANT; MOTHER; PREGNANCY COMPLICATION; VERTICAL TRANSMISSION;

FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; INFANT; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; MOTHERS; PREGNANCY COMPLICATIONS, INFECTIOUS;

EID: 85043437377     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMe1801662     Document Type: Editorial

References (12)

1. Schweitzer A, Horn J, Mikolajczyk RT, Krause G, Ott JJ. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. Lancet 2015; 386: 1546-55.
2. Global hepatitis report, 2017: executive summary. Geneva: World Health Organization, 2017 (http://www .who .int/ hepatitis/ publications/ global-hepatitis-report2017-executive-summary/ en/ ).
3. Wiseman E, Fraser MA, Holden S, et al. Perinatal transmission of hepatitis B virus: an Australian experience. Med J Aust 2009; 190: 489-92.
4. Immunization, vaccines and biologicals: data, statistics and graphics. Geneva: World health Organization, 2017 (http://www .who .int/ immunization/ monitoring-surveillance/ data/ en).
5. Breakwell L, Tevi-Benissan C, Childs L, Mihigo R, Tohme R. The status of hepatitis B control in the African region. Pan Afr Med J 2017; 27: Suppl 3:17.
6. Keane E, Funk AL, Shimakawa Y. Systematic review with meta-analysis: the risk of mother-to-child transmission of hepatitis B virus infection in sub-Saharan Africa. Aliment Pharmacol Ther 2016; 44: 1005-17.
7. Pan CQ, Duan Z, Dai E, et al. Tenofovir to prevent hepatitis B transmission in mothers with high viral load. N Engl J Med 2016; 374: 2324-34.
8. Jourdain G, Ngo-Giang-Huong N, Harrison L, et al. Tenofovir versus placebo to prevent perinatal transmission of hepatitis B. N Engl J Med 2018; 378: 911-23.
9. Terrault NA, Bzowej NH, Chang KM, Hwang JP, Jonas MM, Murad MH. AASLD guidelines for treatment of chronic hepatitis B. Hepatology 2016; 63: 261-83.
10. European Association for the Study of the Liver. EASL 2017 clinical practice guidelines on the management of hepatitis B virus infection. J Hepatol 2017; 67: 370-98.
11. Sarin SK, Kumar M, Lau GK, et al. Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update. Hepatol Int 2016; 10: 1-98.
12. Spearman CW, Afihene M, Ally R, et al. Hepatitis B in sub- Saharan Africa: strategies to achieve the 2030 elimination targets. Lancet Gastroenterol Hepatol 2017; 2: 900-9.